Q3 2025 Holdings
Filed 2025-11-14 | 37 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $331.9M | 3,525,000 | 16.2% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $121.1M | 1,400,000 | 5.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $108.4M | 2,700,000 | 5.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $104.1M | 7,250,000 | 5.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $96.1M | 4,692,809 | 4.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $93.9M | 2,338,287 | 4.6% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $92.9M | 3,096,754 | 4.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $91.3M | 1,350,000 | 4.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $88.7M | 17,000,000 | 4.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $78.3M | 3,028,335 | 3.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $69.1M | 2,850,000 | 3.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $69.1M | 3,200,000 | 3.4% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $68.1M | 1,025,000 | 3.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $60.3M | 2,418,476 | 2.9% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $56.0M | 585,000 | 2.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $55.4M | 4,075,478 | 2.7% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $47.2M | 3,375,000 | 2.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $42.8M | 5,700,000 | 2.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $42.5M | 750,000 | 2.1% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $38.0M | 3,225,000 | 1.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $34.9M | 3,780,055 | 1.7% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $33.7M | 1,753,054 | 1.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $33.3M | 1,988,084 | 1.6% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $30.3M | 500,000 | 1.5% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $25.6M | 1,000,000 | 1.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $24.5M | 7,692,300 | 1.2% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $23.7M | 1,500,000 | 1.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $12.6M | 1,500,000 | 0.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $11.5M | 290,000 | 0.6% |
| Pepgen Inc(PEPG) | COM | 713317105 | $10.9M | 2,357,319 | 0.5% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $9.6M | 800,000 | 0.5% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $8.8M | 4,401,500 | 0.4% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $8.7M | 5,397,488 | 0.4% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.9M | 750,000 | 0.4% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $6.1M | 483,000 | 0.3% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $5.6M | 1,575,000 | 0.3% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $5.4M | 450,829 | 0.3% |